{"id":"W4319333837","doi":"10.1001/jama.2022.25029","title":"Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy","year":2023,"lang":"en","type":"article","venue":"JAMA","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Eye Institute","keywords":"Medicine; Aflibercept; Diabetic retinopathy; Visual acuity; Ophthalmology; Diabetes mellitus; Randomized controlled trial; Macular edema; Retinopathy; Clinical trial; Surgery; Bevacizumab; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004454643,0.002224666,0.003051224,0.0006478275,0.0008076005,0.00161546,0.001115792,0.003378686,0.008060558],"category_scores_gemma":[0.006350748,0.0009692056,0.002779255,0.0005478687,0.001253586,0.001253293,0.0007089934,0.003031874,0.001012229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001574368,"about_ca_system_score_gemma":0.003887288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003238853,"about_ca_topic_score_gemma":0.007183446,"domain_scores_codex":[0.9963591,0.002011494,0.0003301673,0.0005061144,0.0003247458,0.0004684013],"domain_scores_gemma":[0.9975739,0.0004623985,0.0009580594,0.0002227371,0.0002845856,0.0004984117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9887627,0.002990968,0.0006944361,0.0004907675,0.0009927975,0.00002822634,0.00002111835,0.0001427489,0.0006561094,0.0001054457,0.0008559491,0.004258808],"study_design_scores_gemma":[0.9881316,0.009815949,0.00110028,0.00002990227,0.0002436535,0.000008671297,0.000005333699,0.0001506601,0.00009247602,0.000099669,0.0003149305,0.000006872433],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8733653,0.005851687,0.002212975,0.002366115,0.003157456,0.09712462,0.005792886,0.0004836464,0.009645304],"genre_scores_gemma":[0.8891942,0.001799504,0.005064977,0.003607669,0.001034309,0.08594033,0.002777539,0.00004310294,0.01053832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008060558,"threshold_uncertainty_score":0.0269652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03195225380985604,"score_gpt":0.3833723109497037,"score_spread":0.3514200571398476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}